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Introduction
Takayasu’s arteritis (TA) is a chronic inflammatory vascular 
disease of unknown origin. It often affects the aortic arch and 
its main branches, although it can affect other segments of the 
aorta as well as pulmonary and renal arteries1,2.
This arteritis can result in systemic arterial hypertension 
(SAH), cerebral vascular accident (CVA), aortic failure (AF), 
renal failure (RF), intermittent claudication (IC) or congestive 
heart failure (CHF)3.
 Women are more often affected than men, at a proportion 
of 4:1 and its incidence is higher in the second and third 
decades of life. The diagnosis of TA in pregnant women is 
rare; however, when it affects pregnant women, hypertension, 
usually of the renovascular type, can be observed in more than 
50% of the cases and determines higher maternal-fetal risk4. 
Case Report
The patient, R.S.S., was a 17-year-old black female who 
had been hypertensive since 12 years of age. She had an 
echocardiographic diagnosis of aorta coarctation and was 
pregnant for third time. The first pregnancy had ended in 
miscarriage at six weeks of gestation, four years before, and 
the second pregnancy had resulted in premature birth and fetal 
death at seven months of gestation, two years before. 
The patient was admitted at our Institution on March 
2006, complaining of cephalea, dyspnea at moderate 
physical exertion, palpitations and intermittent claudication. 
She was at the second trimester of her third pregnancy (24 
weeks) and presented high blood pressure levels in the upper 
limbs – systolic pressure (SAP) = 180 mmHg and diastolic 
pressure (DAP) = 110 mmHg – and decreased BP levels in the 
lower limbs – SAP = 110 mmHg and DAP = 60 mmHg. 
An aortography was carried out to define the procedure 
for the treatment of aorta coarctation, which showed a 
narrowing in the distal 2/3 of the descending thoracic aorta, 
with parietal irregularities, presence of small- and medium-
caliber collateral circulation and important obstruction in 
the distal extremity of this segment (proximal diameter 
=13.9 mm x distal diameter =2.5 mm). The angiographic 
aspect was suggestive of TA and a balloon-catheter dilation 
was carried out at the area with the highest stenosis (i.e., the 
smallest luminal area).
At the end of the procedure, there was an increase from 
2.5 mm to 7.5 mm in the diameter of the area with the highest 
stenosis and the maximum aortic gradient decreased from 112 
mmHg to 61 mmHg (decrease of 51 mmHg).
A Doppler ultrasonography (USG), performed during the 
hospital stay, showed the involvement of the proximal third of 
the left renal artery and a normal uteroplacental flow. 
The patient remained hypertensive (SAP=160 mmHg 
and DAP=90 mmHg) although she received propranolol 
(60 mg/day), nifedipine (60 mg/day) and prednisone (30 
mg/day) in association with alpha-methyldopa (1.5 g/day), 
which the patient used, with a slight improvement in SAH 
(150 x 90 mmHg). The patient presented improvement of 
symptoms and was discharged.
At the 36th week of gestation, the patient was admitted to the 
hospital again, complaining of cephalea and SAH (170 x 100 
mmHg). A new Doppler USG showed symmetrical intrauterine 
growth retardation, with an estimated fetal weight of 1,935 g 
(expected fetal weight: 2,813 g for the gestational age) and 
moderate increase in the uteroplacental flow resistance.
The obstetric medical team decided for the pregnancy 
resolution when the patient went into labor, due to the 
arterial hypertension peaks of 230x120 mmHg during uterine 
contractions, leading to acute fetal distress.
The delivery by Caesarean section was performed, with no 
maternal or fetal adverse events and maternal BP monitoring, 
with SAP remaining between 150 and 180 mmHg. The infant’s 
birth weight was 1,990 g, with 1st-minute and 5th-minute 
Apgar scores of 9 and 9, respectively. The newborn received 
rooming-in care, remaining in the same hospital room as the 
mother and both were discharged five days after the delivery. 
The patient received the same medications throughout the 
postpartum period, which were gradually decreased at the 
outpatient clinic 15 days after the delivery. 
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We describe here the pregnancy follow-up and outcome 
in a patient with Takayasu’s arteritis, with a detailed account 
of the complications during gestation and delivery and the 
impact of the disease on the newborn’s health.
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The decision to perform a percutaneous aortoplasty 
was made by the hemodynamic team, due to the severity 
of the stenosis and the important clinical manifestation of 
the disease. There was an important improvement in the 
stenosis and distal flow, resulting in the attenuation of the 
SAH, probably maintained by the renovascular involvement. 
However, it allowed, together with the anti-hypertensive 
medication, the maintenance of the pregnancy up to the 
36th week of gestation.
The medications used were alpha-methyldopa, which is 
harmless in pregnancy (Class A), propranolol, which has a 
dose-dependent effect and is safe up to 60 mg/day; higher 
doses can cause IUGR and premature birth (Class B) and 
nifedipine, which up to 60mg/day is also considered Class B7. 
As the patient presented increased blood sedimentation rate 
(100 mm), probably reflecting the disease activity, she was 
given corticosteroids at a dose of 30 mg/day. Pregnancy does 
not interfere with the evolution of Takayasu’s arteritis1-5, 8, 10. 
The delivery by Caesarean section was a decision made by 
the obstetric team, considering the high blood pressure levels, 
which at the start of labor reached 230 x 120 mmHg. 
Conclusion
Although it is a potentially severe pathology during 
pregnancy, with a maternal mortality of 4-5%2 (against 
130/100,000 in the general population), a successful 
pregnancy in TA is possible if followed adequately, aiming 
at the control of SAH, which is often observed in these 
patients. Although the management is eminently clinical, 
the decision to intervene and the ideal moment to do it 
can determine a better evolution and higher safety for 
the pregnancy. In the present case, we believe that the 
intervention that allowed the pregnancy to reach the 
36th week was crucial, considering that the two previous 
gestations had been unsuccessful. 
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The patient is currently still hypertensive and uses captopril 
(75 mg/day) and hydrochlorothiazide (25 mg/day).
Discussion
Takayasu’s arteritis has a worldwide distribution, with 
the highest incidences being found in Japan, East and South 
Asia and India1. Its etiology is still poorly understood and 
genetic factors as well as autoimmunity with the presence 
of histocompatibility antigens, particularly HLA A9, A10, B5, 
BW40, BW52, DQW1, DR2, DR4, DR7, DW3 and DW12, 
are the main postulated causes. The presence of these antigens 
is associated with a worse prognosis².
 Infections have also been implicated in the pathogenesis 
of the disease, especially tuberculosis, which as a high 
prevalence in this population (20 to 25%) and can function as 
an immunological trigger or as a chronic antigenic stimulation 
of the disease2.
 The clinical manifestations range from asymptomatic 
patients with pulse alterations only, to a large neurological 
involvement such as hemorrhagic cerebral vascular accident 
and are due to the obstructive process of the aortic arch and 
its main branches5.
Ishikawa et al6, in a study of 33 pregnancies and 50 more 
cases from the literature, described complications in the 
pregnancy-puerperium cycle in 61.4% of the cases and 4.8% 
of maternal death; the latter were more frequent in the 3rd 
trimester and delivery (65%) and in the postpartum period 
(37%). The main complications were CHF, SAH and stroke, 
with 4 of them being the hemorrhagic type. 
According to the Brazilian consensus on cardiopathy 
and pregnancy7, the fetal risks include intrauterine growth 
retardation (IUGR) in 18% and intrauterine fetal death in 
2-5%. The patient had had a miscarriage and a fetal death, 
which is in accordance with the literature and emphasizes the 
necessary care for these patients. 
Hung et al8 reported a successful pregnancy in a 23-year-
old woman submitted to a bypass surgery. The drugs used by 
the patient were similar to the ones used in our institution and 
the delivery was postponed until the 33rd week of gestation. 
In this case, the patient also underwent a caesarean section, 
due to the severity of the condition. No cases of percutaneous 
treatment during pregnancy were found in the literature. 
The percutaneous aortoplasty was chosen due to the small risk 
of radiation for the fetus in the second trimester, with adequate 
abdominal protection, as well as the decreased mortality when 
compared to the conventional surgery (30% x 5%)9.
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